125I-labeled gold nanorods for targeted imaging of inflammation.

For better examination of inflammation, we designed inflammation-targeted nuclear and optical dual-modality contrast agents prepared by I-125 radiolabeling of gold nanorods (GdNRs) conjugated with anti-intercellular adhesion molecule 1 (ICAM-1) antibody. The bioactivity and specific binding of the PEGylated (125)I-ICAM-GdNR conjugates to the ICAM-1 was validated through ELISA testing. Inflammation-targeted imaging was then conducted on an adjuvant-induced arthritic rat model which demonstrated an elevation of ICAM-1 level in the affected ankle joints. Facilitated by the I-125 radioisotope and the whole-body imaging via the Gamma camera, the time-dependent distribution of the systemically injected agent as well as the uptake of the agent in the inflammatory articular tissues could be examined conveniently and quantitatively. The success in targeted delivery of gold nanoparticles to inflammatory tissue enables both nuclear and optical imaging of inflammation at molecular or cellular level. Other than diagnosis, radiolabeled gold nanoparticles also hold promise for targeted therapy of a variety of disorders.

[1]  D. Felson,et al.  The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis. Results of two metaanalyses. , 1990, Arthritis and rheumatism.

[2]  D. Shieh,et al.  Photoacoustic Imaging of Multiple Targets Using Gold Nanorods , 2007, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

[3]  Michael Loran Dustin,et al.  Induction by IL 1 and interferon-γ: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J. Immunol. 1986. 137: 245-254. , 2011, Journal of immunology.

[4]  H. Wheeler,et al.  Experiences with the use of radioactive colloidal gold in the treatment of cancer. , 1955, Annals of surgery.

[5]  Ji-Xin Cheng,et al.  Gold Nanorods as Contrast Agents for Biological Imaging: Optical Properties, Surface Conjugation and Photothermal Effects † , 2009, Photochemistry and photobiology.

[6]  P. Klimiuk,et al.  Soluble adhesion molecules (ICAM-1, VCAM-1, and E-selectin) and vascular endothelial growth factor (VEGF) in patients with distinct variants of rheumatoid synovitis , 2002, Annals of the rheumatic diseases.

[7]  R. Dierckx,et al.  Molecular imaging of rheumatoid arthritis by radiolabelled monoclonal antibodies: new imaging strategies to guide molecular therapies , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[8]  Timothy A. Springer,et al.  Adhesion receptors of the immune system , 1990, Nature.

[9]  Priyabrata Mukherjee,et al.  Biological properties of "naked" metal nanoparticles. , 2008, Advanced drug delivery reviews.

[10]  Kenji Kaneko,et al.  Modification of gold nanorods using phosphatidylcholine to reduce cytotoxicity. , 2006, Langmuir : the ACS journal of surfaces and colloids.

[11]  Bengt Fadeel,et al.  Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications. , 2010, Advanced drug delivery reviews.

[12]  A. Hopkins,et al.  ICAM-1: targeted docking for exogenous as well as endogenous ligands. , 2004, Advanced drug delivery reviews.

[13]  T. Niidome,et al.  In vivo monitoring of intravenously injected gold nanorods using near-infrared light. , 2008, Small.

[14]  Michael Loran Dustin,et al.  Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). , 1986, Journal of immunology.

[15]  Gert Storm,et al.  Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system , 1995 .

[16]  Jürgen Beuthan,et al.  Correction of motion artefacts and pseudo colour visualization of multispectral light scattering images for optical diagnosis of rheumatoid arthritis , 2009, Saratov Fall Meeting.

[17]  D. Elewaut,et al.  Monoclonal Antibody Therapy in Rheumatoid Arthritis , 1994, Clinical Immunotherapeutics.

[18]  A. Khademhosseini,et al.  Covalent immobilization of p-selectin enhances cell rolling. , 2007, Langmuir : the ACS journal of surfaces and colloids.

[19]  Peng Thim Fan,et al.  The use of biological agents in the treatment of rheumatoid arthritis. , 2007, Annals of the Academy of Medicine, Singapore.

[20]  Chao-Liang Wu,et al.  Amelioration of collagen-induced arthritis in rats by nanogold. , 2007, Arthritis and rheumatism.

[21]  Henk Visser,et al.  Early diagnosis of rheumatoid arthritis. , 2005, Best practice & research. Clinical rheumatology.

[22]  Paul L Carson,et al.  Photoacoustic tomography of joints aided by an Etanercept-conjugated gold nanoparticle contrast agent—an ex vivo preliminary rat study , 2008, Nanotechnology.

[23]  C. Shaw,et al.  Gold-Based Therapeutic Agents , 1999 .

[24]  Hongwei Liao and,et al.  Gold Nanorod Bioconjugates , 2005 .

[25]  L. Liz‐Marzán,et al.  Chemical sharpening of gold nanorods: the rod-to-octahedron transition. , 2007, Angewandte Chemie.

[26]  Paul Mulvaney,et al.  Gold nanorods: Synthesis, characterization and applications , 2005 .

[27]  E. W. Hahn,et al.  The prevention of Ehrlich ascites tumor using intraperitoneal colloidal 198Au. Dose vs. size of inoculum. , 1975, Radiology.

[28]  A. Menrad,et al.  Molecular Imaging of Tumor Angiogenesis , 2004, Annals of the New York Academy of Sciences.

[29]  Stefan Kammerer,et al.  Role of ICAM1 in invasion of human breast cancer cells. , 2005, Carcinogenesis.

[30]  R. Priori,et al.  New radiopharmaceuticals for imaging rheumatoid arthritis. , 2006, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[31]  S. W. Root,et al.  Intracavitary colloidal radiogold in the treatment of effusions caused by malignant neoplasms. , 1953, Annals of surgery.

[32]  Massoud Motamedi,et al.  Engineering of hetero-functional gold nanorods for the in vivo molecular targeting of breast cancer cells. , 2009, Nano letters.

[33]  Buchsbaum Hj,et al.  The use of radioisotopes as adjunct therapy of localized ovarian cancer. , 1975 .

[34]  G. Dalldorf Studies of the Sparing Effect of Lymphocytic Choriomeningitis on Experimental Poliomyelitis , 1939, The Journal of Immunology.

[35]  Xiaohua Huang,et al.  Peptide-conjugated gold nanorods for nuclear targeting. , 2007, Bioconjugate chemistry.

[36]  Yoshiya Tanaka,et al.  β1 integrin–mediated signaling induces intercellular adhesion molecule 1 and Fas on rheumatoid synovial cells and Fas‐mediated apoptosis , 2003 .

[37]  C. Shaw III Gold-based therapeutic agents. , 1999, Chemical reviews.

[38]  L. Davis,et al.  Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1. , 1994, Arthritis and rheumatism.

[39]  A. Agarwal,et al.  Dual-mode imaging with radiolabeled gold nanorods. , 2011, Journal of biomedical optics.

[40]  Lihong V. Wang,et al.  Photoacoustic tomography of a nanoshell contrast agent in the in vivo rat brain , 2004 .

[41]  Joseph Irudayaraj,et al.  Gold nanorod/Fe3O4 nanoparticle "nano-pearl-necklaces" for simultaneous targeting, dual-mode imaging, and photothermal ablation of cancer cells. , 2009, Angewandte Chemie.

[42]  Hiromu Ito,et al.  Intercellular adhesion molecule-1 mediates the inhibitory effects of hyaluronan on interleukin-1β-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts via down-regulation of NF-κB and p38 , 2006 .

[43]  Chulhong Kim,et al.  Noninvasive in vivo spectroscopic nanorod-contrast photoacoustic mapping of sentinel lymph nodes. , 2009, European journal of radiology.

[44]  H. Latourette,et al.  The use of radioisotopes as adjunct therapy of localized ovarian cancer. , 1975, Seminars in Oncology.

[45]  Takuro Niidome,et al.  PEG-modified gold nanorods with a stealth character for in vivo applications. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[46]  D. Mooney,et al.  Targeted delivery of nanoparticles to ischemic muscle for imaging and therapeutic angiogenesis. , 2011, Nano letters.

[47]  C. Ritchlin,et al.  The diagnosis and treatment of early psoriatic arthritis , 2009, Nature Reviews Rheumatology.

[48]  C. Roland,et al.  ICAM-1 expression determines malignant potential of cancer. , 2007, Surgery.

[49]  A. Agarwal,et al.  Synthesis and bioevaluation of 125I-labeled gold nanorods , 2011, Nanotechnology.

[50]  David T. Felson,et al.  THE COMPARATIVE EFFICACY AND TOXICITY OF SECOND LINE DRUGS IN RHEUMATOID ARTHRITIS , 1990 .